Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Filed May 3, 2012 · 10-Q · 33 days after period end · 0001062822-12-000021
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenue | $300.00K | $596.00K |
| Net Income | -$29.87M | -$29.63M |
| EPS Diluted | -$0.06 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 3, 2012 · 33 d after period end
